Does IPRATROPIUM\XYLOMETAZOLINE Cause Lung opacity? 11 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 11 reports of Lung opacity have been filed in association with IPRATROPIUM\XYLOMETAZOLINE. This represents 11.6% of all adverse event reports for IPRATROPIUM\XYLOMETAZOLINE.
11
Reports of Lung opacity with IPRATROPIUM\XYLOMETAZOLINE
11.6%
of all IPRATROPIUM\XYLOMETAZOLINE reports
11
Deaths
11
Hospitalizations
How Dangerous Is Lung opacity From IPRATROPIUM\XYLOMETAZOLINE?
Of the 11 reports, 11 (100.0%) resulted in death, 11 (100.0%) required hospitalization, and 11 (100.0%) were considered life-threatening.
Is Lung opacity Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for IPRATROPIUM\XYLOMETAZOLINE. However, 11 reports have been filed with the FAERS database.
What Other Side Effects Does IPRATROPIUM\XYLOMETAZOLINE Cause?
Stress (74)
Appendicitis (73)
Ascites (73)
Hyponatraemia (73)
Appendicolith (72)
Cardiogenic shock (72)
General physical health deterioration (72)
Multiple organ dysfunction syndrome (72)
Ventricular fibrillation (72)
Abdominal distension (70)
What Other Drugs Cause Lung opacity?
ALBUTEROL (296)
PREDNISONE (216)
TIOTROPIUM (196)
LANSOPRAZOLE (166)
IPRATROPIUM (157)
ACETAMINOPHEN (153)
MEPOLIZUMAB (149)
PANTOPRAZOLE (140)
BUDESONIDE\FORMOTEROL (139)
MONTELUKAST (137)